1. Serum midkine as non-invasive biomarker for detection and prognosis of non-small cell lung cancer
- Author
-
Louisa Stern, Erik Mueller, Eugen Bellon, Matthias Reeh, Rainer Grotelueschen, Cenap Guengoer, Nathaniel Melling, Mara Goetz, Daniel R. Perez, Jakob R. Izbicki, Tamina Rawnaq-Möllers, and Tarik Ghadban
- Subjects
Medicine ,Science - Abstract
Abstract Lung cancer continues to be the leading cause for cancer-related deaths in men and women worldwide. Sufficient screening tools enabling early diagnosis are essential to improve patient outcomes. The aim of this study was to evaluate serum midkine (S-MK) both as a diagnostic and prognostic biomarker in non-small cell lung cancer (NSCLC). This single-center analysis included 59 NSCLC patients counting 30 squamous cell cancers and 29 adenocarcinomas. Preoperative S-MK concentration was determined using ELISA. Patients were followed up to five years. S-MK was found to be significantly overexpressed in patients with NSCLC compared to healthy controls (p
- Published
- 2021
- Full Text
- View/download PDF